🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🍺❌Alcohol-related Liver Disease (ArLD) is preventable. On #WorldLiverDay, let's work together to implement effective policies to reduce alcohol consumption and save lives. 🚨Remember: there is NO safe level of alcohol consumption. #ArLD #LiverHealth #Alcohol #Livertwitter

Check out our new paper on sarcopenia🏋🏻 📌 39 studies and >10.000 patients 📈 Higher mortality, but do we do define sarcopenia? ✅ Confirmed prognostic impact of SMI and EASL/AASLD cut-offs ❓Role of psoas muscle, definitions too heterogeneous to be validated JHEP Reports

👉Join the Baveno Cooperation at the EASL ILC in Milano‼️ 🗓️Two events, both on Saturday June 8 1⃣ EASL-CLIF Joint Future of Hepatology Session: Decompensated Cirrhosis 🕒 08:30-09:45 AM, Room: Brown 3 🔗events-apps.easl.eu/easl2024/en-GB… and ... 👇

In 83,825 patients with obesity, semaglutide (vs. other anti-obesity meds) associated with 50%-56% lower risk of alcohol use disorder. Findings replicated patients with type 2 diabetes Nature Communications More compelling data, await RCT results nature.com/articles/s4146…

Getting ready for a great EASL ILC - don’t forget to join the Baveno Cooperation Track Hub on Saturday! Guadalupe GarciaTsao Thomas Reiberger cristina jaumebosch Elton Dajti Susana Rodrigues EASLnews

New content online: Endogenous ethanol production in health and disease dlvr.it/T7qshl

What a way to start my #EASL2024! One of my favorite topics and Hepatologists ⭐️⁦EASLnews⁩

Packed Baveno Cooperation Track Hub at the #EASLCongress ! Welcoming new members interested in portal hypertension - we particularly welcome young investigators! Check out pur website and learn how to become member The Baveno Cooperation: an EASL Consortium bavenocoop.net

Key takeaways from The Baveno Cooperation: an EASL Consortium Track Hub: 1⃣ Become a member, it´s free‼️ 2⃣ Requirements❓Passion for PH research regardless of your expertise 3⃣ Join via our website: bavenocoop.net 4⃣ Upload: CV and motivational letter (1 page max) 5⃣ Sponsorships warmly welcomed‼️

New content online: Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus Statement dlvr.it/T815dk

Commercial determinants of health! The Killers: Alcohol, tobacco, ultra-processed foods and fossil fuels cause 2.7 million deaths in the Europe every year We know why, we know how to change it - yet nothing happens?? EASL Advocacy Shira zelber sagi Jeffrey V. Lazarus WHO report 👇

Amplía tus conocimientos en la metodología para el estudio de las enfermedades hepáticas cursado esta asignatura troncal. De la mano de los mejores profesores y con material docente plenamente actualizado. No te quedes sin tu plaza! Inicio de curso el 03/10!

🔔 Reminder: Hepatologia em Rede Encontra-se a decorrer um estudo sobre a epidemiologia da Colangite Esclerosante Primária em Portugal, que não é completamente conhecida. 👉 Para participar neste estudo, envie e-mail para: [email protected]

Consumo de álcool mata 2,6 milhões de pessoas por ano sicnoticias.pt/pais/2024-06-2…

I’m really looking forward to starting this journey - it’s a great honor serving in the team of senior editors for the Journal of Hepatology together with a fantastic group of colleagues! EASLnews Faculty of Medicine, University of Bern Insel Gruppe

✅ interested in factors modulating cirrhosis regression after control of the etiology? ➡️ Brand new in JHep! Metabolic phenotyping of patients with Advanced Chronic Liver Disease for better characterization of Cirrhosis Regression ⁦Yuly Mendoza⁩ sciencedirect.com/science/articl…

Can we start NSBBs based only on non-invasive tests?🤔 🔥 Check out our new paper addressing this issue in the unique PREDESCI trial cohort 🔥 Thank you Annalisa Berzigotti and jaumebosch for the opportunity to work with this wonderful study group The Baveno Cooperation: an EASL Consortium journal-of-hepatology.eu/article/S0168-…

On 9th May I will take over as the 1st female Secretary General EASLnews. I am looking for a partner to join me on my leadership journey and join our global hepatology platform🌎 E - Education A - Advocacy S - Science L - Leadership DM or 📞 for an informal chat. #livertwitter

Sepsis is a life-threatening, heterogeneous disorder involving a dysregulated immune response to infection. Research to identify subtypes and targeted therapies for host dysregulation is ongoing. Read the full review: nej.md/3OFrGZR

#GUTImage from the #GUTCommentary by Dr Iuliana Pompilia Radu on "Is mailed outreach and patient navigation a perfect solution to improve HCC screening?" via bit.ly/3YXsgYN #HCC